ARCHIVES

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Ultmann Appeals For Better Funding, Cancer Act Renewal

June 28, 1985

DCCR Plans Three Multiple Contracts In Pain Control

February 17, 1978

New Screening Tool Helps GP ID Hereditary BC Risk

October 27, 2006

Blood Donors With Undertrain HTLV-3 Should Be Notified, Consensus Panel Says

July 18, 1986

Carcinogenesis Testing Moved Out of DCCP To New Status As Division, Giving Rall More Authority

September 14, 1979

In Brief: Survey Finds Most Localities Have Smoking Limits; Martocchio, Rickel ONS Award Speakers

April 24, 1987